A reduction in AAA-derived microbial metabolites (e.g., phenyllactate, indolelactate, imidazolyllactate) was associated with monocyte-specific downregulation of aryl hydrocarbon receptor (AhR)-mediated signaling, reflecting diminished immunoregulatory tone in MS. The gene discussed is AHR; the disease is triple-A syndrome.